CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

NCT04257175 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: CAR-T CD19

Sponsor

Sheba Medical Center